Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years. J of Skin 2025, 9 (2), s573. https://doi.org/10.25251/skin.10.supp.573.